Spire Healthcare Group plc

('Spire Healthcare', 'the Company' or 'the Group')

Change in Spire Healthcare's directors

6 March 2025

Spire Healthcare Group plc (LSE: SPI), a leading independent healthcare group in the UK, today announces that, having completed over 10 years of service, Professor Dame Janet Husband has decided to step down from the Board at the Company's annual general meeting on 14 May 2025 and will not seek re-election by shareholders. The Company is pleased to announce the following Non-Executive Director appointments effective as of today.

Non-Executive Director appointments

Sir David Sloman will join as a non-independent Non-Executive Director. Sir David will become a member of the Company's Clinical Governance and Safety Committee on appointment and will replace Dame Janet as chair on 14 May 2025. He will also take on the role of Vice Chair from this date.

Sir David has had a long career in healthcare management, predominantly in the NHS. He has held several CEO roles at several NHS trusts, including the Royal Free London NHS Foundation Trust, the Whittington Hospital NHS Trust and NHS Haringey Trust. During December 2021 and August 2023, he was the COO of NHS England, where he was responsible for overseeing all NHS operational delivery, including the response to the COVID-19 pandemic. Sir David is a non-executive director of AXA UK and Ireland, a board member of Health Data Research UK, a fellow of the Royal Society of Medicine, a senior fellow of the Institute for Healthcare Improvement and a trustee of the Royal College of Radiologists. As a result of Sir David's appointment with AXA UK and Ireland, the Company does not consider him to be independent.

Jill Anderson will join as an independent Non-Executive Director. Jill will become a member of the Company's Audit and Risk Committee on appointment and will become chair from 14 May 2025. She will also become a member of the Remuneration Committee on appointment. Jill has 30 years' experience in the healthcare sector, including executive responsibility in finance, commercial, research and supply chain functions across large multinational organisations principally with GSK plc. She is a trustee of Amref UK, an NGO focused on healthcare in Africa, and was an associate non-executive director of London Ambulance Service until 2022.

Sir Ian Cheshire, Spire Healthcare's Non-Executive Chairman, said:

"We are delighted that both Jill and Sir David have agreed to join Spire's Board. The breadth of their expertise and experience in healthcare will be a highly valuable addition to our Board and the Company. I look forward to welcoming Sir David as the new chair of the Clinical Governance and Safety Committee and Jill as the new chair of the Audit and Risk Committee.

"I would also like to thank Dame Janet for her considerable contribution to Spire since the Company listed in 2014 and also Debbie White for chairing the Audit and Risk Committee on an interim basis."

In accordance with the UK Listing Rules, there is no further information required to be disclosed pursuant to UKLR 6.4.8R.

For further information please contact:

About Spire Healthcare

Spire Healthcare is the leading independent healthcare group in the United Kingdom, running 38 hospitals and over 50 clinics, medical centres and consulting rooms across England, Wales and Scotland. It operates a network of private GPs and provides occupational health services to over 800 corporate clients.

Working in partnership with over 8,600 experienced consultants, Spire Healthcare delivered tailored, personalised care to over 1 million inpatients, outpatients and daycase patients, and occupational health programme clients, in 2023, and is the leading private provider, by volume, of knee and hip operations in the United Kingdom. It also delivers a range of private and NHS mental health, musculoskeletal and dermatological services under the Vita Health Group brand.

Spire Healthcare's well-located and scalable hospitals have delivered successful and award-winning outcomes, positioning the group well with patients, consultants, the NHS, GPs and Private Medical Insurance ('PMI') providers. 98% of Spire Healthcare's inspected locations are rated 'Good', 'Outstanding' or the equivalent by health inspectors in England, Wales and Scotland.

Spire Healthcare is listed on the London Stock Exchange and is a member of the FTSE 250.